- Home
- CCJ vs BNTX Comparison
CCJ vs BNTX Comparison
Compare CCJ & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCJ
- BNTX
- Stock Information
- Founded
- CCJ 1987
- BNTX 2008
- Country
- CCJ Canada
- BNTX Germany
- Employees
- CCJ N/A
- BNTX N/A
- Industry
- CCJ Other Metals and Minerals
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCJ Basic Materials
- BNTX Health Care
- Exchange
- CCJ Nasdaq
- BNTX Nasdaq
- Market Cap
- CCJ 25.2B
- BNTX 23.9B
- IPO Year
- CCJ N/A
- BNTX 2019
- Fundamental
- Price
- CCJ $61.31
- BNTX $121.98
- Analyst Decision
- CCJ Strong Buy
- BNTX Strong Buy
- Analyst Count
- CCJ 4
- BNTX 14
- Target Price
- CCJ $66.56
- BNTX $141.60
- AVG Volume (30 Days)
- CCJ 4.4M
- BNTX 1.1M
- Earning Date
- CCJ 11-07-2024
- BNTX 11-04-2024
- Dividend Yield
- CCJ 0.19%
- BNTX N/A
- EPS Growth
- CCJ N/A
- BNTX N/A
- EPS
- CCJ 0.19
- BNTX N/A
- Revenue
- CCJ $2,069,888,595.00
- BNTX $3,390,698,192.00
- Revenue This Year
- CCJ $17.44
- BNTX N/A
- Revenue Next Year
- CCJ $8.65
- BNTX N/A
- P/E Ratio
- CCJ $317.43
- BNTX N/A
- Revenue Growth
- CCJ 23.31
- BNTX N/A
- 52 Week Low
- CCJ $35.43
- BNTX $76.53
- 52 Week High
- CCJ $61.42
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- CCJ 68.84
- BNTX 61.56
- Support Level
- CCJ $57.74
- BNTX $112.96
- Resistance Level
- CCJ $61.05
- BNTX $121.80
- Average True Range (ATR)
- CCJ 2.23
- BNTX 4.86
- MACD
- CCJ 0.24
- BNTX 1.13
- Stochastic Oscillator
- CCJ 94.70
- BNTX 97.68
About CCJ Cameco Corporation
Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe. one of those uranium producers. Cameco has three reportable segments, uranium, fuel services and Westinghouse. It derives maximum revenue from Uranium Segment. It has some projects namely; Millennium, Yeelirrie, Kintyre and Exploration. The company operates in Canada, Kazakhstan, Germany, Australia and United States.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.